World-leading collaborations

Scottish Enterprise, NHS Scotland, four Scottish university medical schools (in Aberdeen, Dundee, Edinburgh and Glasgow) and US pharmaceutical giant Pfizer (formerly Wyeth) have come together to facilitate the Translational Medicine Research Collaboration (TMRC).

Translational Medicine Research Collaboration

TMRC is a world first in translational medicine, combining commercial, clinical and academic expertise to improve understanding of a wide range of diseases.

Pfizer’s investment of £33 million in the first five years of the project will inject more than £50 million in clinical and biomedical research across Scotland by 2012.

The rewards from this major investment and the TMRC will be far reaching including: 

  • Clinical benefits for Scottish patients 
  • Benefits for centres of excellence and clinical research networks 
  • Benefits for teaching, research and education 
  • Benefits for biotechnology and commercialisation

If your company has investment interests in translational medicine in Scotland, then TMRC offers potential to work with other organisations and companies, for the longer term.

Health Science Scotland

Health Science Scotland, previously known as the Scottish Academic Health Sciences Collaboration (SAHSC), establishes a world-leading clinical research platform for patient-oriented research.

It builds on the close NHS Scotland and academic partnerships already existing in Aberdeen, Dundee, Edinburgh and Glasgow and, through these, cements links with other Scottish Health Boards and universities.

Take advantage of our world-class expertise in key therapeutic areas of translational medicine research, such as: 

  • Cancer
    • Translational research 
    • Drug metabolism and personalised medicine 
    • Treatment, testing new drugs, diagnostics and therapies 
    • Colon cancer genetics 
    • MRI and PET clinical imaging in breast cancer 
    • Inflammation, auto-immune and bone disorders 
      • Clinical outcome assessment in rheumatoid arthritis 
      • Basic and clinical science in bone disease 
      • Signal transduction therapy − one of the largest collaborations between industry and research in UK 
      • Includes the MRC Centre for Inflammation Research at the University of Edinburgh
      • Neuroscience 
        • Alzheimers research 
        • Schizophrenia and genetics 
        • Ageing cohorts research 
        • Extensive brain imaging research pool
        • Cardiovascular disease – includes the BHF Cardiovascular Research Centre in Glasgow
        • Diabetes and metabolic diseases − includes the Scottish Diabetes Research Network
        • Virology – includes the Specialist Virology Centre in Glasgow

        Explore our research areas and assets on the Health Science Scotland website